Dr. Christin Glorioso is a physician scientist and co-founder and CEO of NeuroAge Therapeutics. NeuroAge is a winner of the US National Institute on Aging Startup Challenge, a winner of the Stanford Longevity Company Competition, and was named one of the top 10 companies to watch in 2023 by Life Science Nation. Dr. Glorioso is a pioneer of aging clocks in the human brain and has published more than 25 scientific papers. She is an expert on AI-based predictive modeling and built the top model out of 104 teams worldwide for US COVID case prediction in the XPRIZE Pandemic Response Challenge. Dr. Glorioso is passionate about community building and also founded and directs the non-profit, Longevity Global. She completed her MD and PhD at the University of Pittsburgh and Carnegie Mellon University Medical Scientist Training Program (MSTP) and her postdoctoral training at MIT.